Drug Profile
Research programme: antifolates - Center for Infectious Disease Research/ GlaxoSmithKline
Alternative Names: antituberculars- Center for Infectious Disease Research/ GlaxoSmithKlineLatest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator Center for Infectious Disease Research; GlaxoSmithKline
- Developer Center for Infectious Disease Research; GSK
- Class Antibacterials; Antituberculars
- Mechanism of Action Cell death modulators; Folate receptor 1 modulators; Folic acid transporter modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mycobacterial infections